Skip to main content
Briefed
Companies

London Stock Exchange · AZNFTSE 100

AstraZeneca

AstraZeneca is a global, science-led pharmaceutical business focused on the research, development and commercialisation of prescription medicines, including oncology, rare disease and biopharmaceutical therapies.

Companies House 02723534Checked 11 September 2026

Legal and market record

Legal nameASTRAZENECA PLC
RegistryPublic limited Company · ActiveIncorporated 17 June 1992 · 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, CB2 0AA
ListingAZN · Main MarketISIN GB0009895292 · FTSE 100
Companies House SIC21100 — Manufacture of basic pharmaceutical products21200 — Manufacture of pharmaceutical preparations46460 — Wholesale of pharmaceutical goods72110 — Research and experimental development on biotechnology

Ownership and control

AstraZeneca PLC is a listed parent company whose ordinary shares trade in London as AZN. Economic ownership changes through public-market trading, so the useful ownership record is the share register and major-holdings disclosures rather than a static controlling-owner label.

A public-company profile is not a real-time shareholder register. Briefed separates the legal entity record from market ownership so a stale or incomplete registry field is not presented as the whole ownership picture.

Primary sources3

registryCompanies House company recordOpen primary recordexchangeLondon Stock Exchange issuer pageOpen primary recordissuerAstraZeneca company overviewOpen primary record

Published by BriefedData checked 11 September 2026

Media

Everything Briefed publishes.

Live News, two editions, an archive going back to the first one, and the standards they are written to.

Read the latest newsGet Briefed Daily, free